In contrast, in breast cancer, SIRT2 regulates the reversible acetylation of PHGDH through TIP60 and promotes the binding of PHGDH and RNF5 to induce PHGDH degradation and reducing serine and glycine derived from glucose metabolism via the serine biosynthesis pathway in (246). Here, PHGDH is linked to breast cancer.